0000000000000000000000000000000000000000000000000000000000000000214385
Research payments
$7,070,176
Through program year 2025, $7,070,176 in research payments was reported against 0000000000000000000000000000000000000000000000000000000000000000214385, across 62 payments, paid by GlaxoSmithKline, LLC..
- Paid by
- GlaxoSmithKline, LLC.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $1,612,971 | 19 |
| 2024 | Research | $3,606,694 | 26 |
| 2021 | Research | $1,701,186 | 15 |
| 2019 | Research | $149,325 | 2 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
1 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.